|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 9/1652 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 9/1647 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/1641 | (2013.01) | ||
| A61K 9/5047 | (2013.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/5031 | (2013.01) |
| (11) | Patento numeris | 3574897 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19180351.9 |
| Europos patento paraiškos padavimo data | 2012-11-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-01-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161561525 P | 2011-11-18 | US |
| (72) |
CHEN, Hunter , US
WALSH, Scott , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | EXTENDED RELEASE FORMULATION COMPRISING POLYMER PROTEIN MICROPARTICLES FOR USE IN THE VITREOUS OF THE EYE FOR TREATING VASCULAR EYE DISORDERS |
| EXTENDED RELEASE FORMULATION COMPRISING POLYMER PROTEIN MICROPARTICLES FOR USE IN THE VITREOUS OF THE EYE FOR TREATING VASCULAR EYE DISORDERS |